It is also interesting to note that overexpression of RAC1G12V didn’t completely rescue the cells treated with shDOCK1 and metformin, suggesting that DOCK1 might have some other potential functions beyond the DOCK1-RAC1 axis to enhance the cancer cell-killing activity of metformin, which warrants further independent investigation. The gene discussed is DOCK1; the disease is cancer.